Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
HR 9644 has been referred to the Ways and Means Committee and the Energy and Commerce Committee so they can consider any provisions that relate to Medicare Advantage medical‑loss‑ratio transparency. The measure would affect Medicare Advantage beneficiaries, plan sponsors and regulators by potentially increasing the openness of cost‑sharing data. No specific actions are outlined yet; the bill is awaiting committee action.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 9644 changes status, plus AI-powered summaries and stage predictions.
Sign up free